Medicare Part D – Page 27 – medicarereport.org

A trusted source for Medicare news and education from the AMAC Foundation.

Medicare spending on weight loss drugs may be lower than previously thought: Report

(By Rylee Wilson for Becker’s Hospital Review ) Medicare spending on GLP-1 medications may not be as high as some

Eileen Cook May 17, 2024 CMS, GLP-1s drugs, Healthcare Finance, medicare, Medicare Part D, Older Adults, Semaglutide

Medicare - General Part D/Prescription Drugs

New KFF Poll Finds that Many Older Voters Are Unaware of Medicare Drug Price Negotiation, But Awareness Has Grown

(By Chris Lee and Craig Palosky for The Kaiser Family Foundation published May 15, 2024) A new KFF poll finds

Eileen Cook May 15, 2024May 15, 2024 medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Seniors

CMS Emerging Health Issues Health Care - General Health Insurance Medicare - General Part D/Prescription Drugs

Poll: 1 in 8 Adults Say They’ve Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease

(By Tammie Smith at The Kaiser Family Foundation published May 10, 2024) About one in eight adults (12%) say they

Eileen Cook May 10, 2024May 10, 2024 CMS, Diabetes, Emerging Healthcare, GLP-1s drugs, Healthcare Costs, heart disease, medicare, Medicare Part D, Mounjaro, Obesity, Ozempic, Wegovy

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Medicare’s financial picture brightens slightly

(By Rylee Wilson for Becker’s Hospital Review ) Medicare’s hospital insurance trust fund is expected to run out in 2036,

Eileen Cook May 7, 2024May 7, 2024 CMS, Hospital Insurance Trust Fund, medicare, Medicare Advantage, Medicare Part D

Health Care Finance Part D/Prescription Drugs

The world is relying on the United States to get value-based drug pricing right

(By Jason Shafrin, Louis Garrison, and Melanie D. Whittington for ST A T) The changing landscape of drug pricing policy

Eileen Cook May 7, 2024May 7, 2024 Health Technology Assessments, Healthcare Costs, Healthcare Finance, Medicare Part D, Value-based drug pricing

Aging Alzheimer’s/Dementia Health Care Finance Health Insurance Medicare - General Medicare Advantage Nursing Homes Part D/Prescription Drugs Women’s Health

10 Key Facts About Women with Medicare

(By Meredith Freed, Juliette Cubanski, Michelle Long, Nancy Ochieng, Tricia Neuman, and Alina Salganicoff for The Kaiser Family Foundation Published:

Eileen Cook May 2, 2024May 2, 2024 Alzheimer’s Disease, CMS, Dementia, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults, Women’s Health

CMS Medicare - General Part D/Prescription Drugs

An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk

(By Chris Lee for The Kaiser Family Foundation published April 24, 2024) In a new analysis, KFF finds that 3.6

Eileen Cook April 29, 2024April 29, 2024 CMS, FDA, medicare, Medicare Part D, Older Adults, Reduce Heart Risk, Semaglutide, Wegovy

Aging CMS FDA Medicare - General Medicare Advantage Part D/Prescription Drugs

A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity

(By Juliette Cubanski, Tricia Neuman, Nolan Sroczynski, and Anthony Damico for The Kaiser Family Foundation Published: Apr 24, 2024) The

Eileen Cook April 24, 2024April 24, 2024 CMS, FDA, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D, Obesity, Older Adults, Ozempic, Wegovy

CMS Health Care Finance Health Insurance Medicare Advantage Pandemic

Medicare Advantage costs begin to stabilize, UnitedHealth says

(By Rylee Wilson for Becker’s Hospital Review ) Rising medical cost trends aren’t going down, but they are stabilizing, UnitedHealth

Eileen Cook April 17, 2024April 17, 2024 CMS, Healthcare Costs, Healthcare Finance, Medicare Advantage, Medicare Part D, pandemic

CMS Medicare - General Medicare Advantage Part D/Prescription Drugs Price Transparency Prior Authorization

Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency

(By Jeannie Fuglesten Biniek, Meredith Freed, and Tricia Neuman for The Kaiser Family Foundation Published: Apr 10, 2024) The Centers

Eileen Cook April 11, 2024April 11, 2024 CMS, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Price Transparency, Prior Authorization